Efficacy and Safety of Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris
Phase 3
Completed
- Conditions
- Acne Vulgaris
- Registration Number
- NCT00441415
- Lead Sponsor
- Galderma R&D
- Brief Summary
The purpose of this study is to demonstrate the non-inferior efficacy of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel when compared to Clindamycin 1% / Benzoyl Peroxide 5% Gel in Subjects with acne vulgaris after a 12-week treatment period.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 272
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Percent change from Baseline in total lesion count (sum of non inflammatory and inflammatory lesions) at week 12.
- Secondary Outcome Measures
Name Time Method Global severity assessment at each post Baseline visit Percent change from Baseline in total inflammatory and non inflammatory lesion counts at each intermediate visit
Trial Locations
- Locations (4)
Paul YAMAUCHI
🇺🇸Santa Monica, California, United States
Steven E. KEMPERS
🇺🇸Fridley, Minnesota, United States
Dr Alicia BUCKO
🇺🇸Albuquerque, New Mexico, United States
Elisabeth ARTHUR
🇺🇸Rochester, New York, United States